Target intelligence / Profile preview

Mitochondrial electron transport chain and mitochondrial reactive oxygen species pools (ETC/mROS)

Target
ETC/mROS
Molecular classification
Enzyme, Transporter, Oxidoreductase, Protein complex
01

Overview

The mitochondrial electron transport chain (ETC) and mitochondrial reactive oxygen species (mROS) pools constitute the central bioenergetic and redox signaling hub of the eukaryotic cell (1.5.1, 1.5.4). Located within the inner mitochondrial membrane, the ETC comprises four multi-subunit enzyme complexes (I-IV) and two mobile electron carriers (ubiquinone and cytochrome c) that facilitate the transfer of electrons to molecular oxygen (1.1.3, 1.5.2). This process generates a proton-motive force used by ATP synthase (Complex V) to produce ATP, while simultaneously producing mROS as a byproduct of electron leakage, primarily at Complexes I and III (1.1.2, 1.2.2). At physiological levels, mROS function as critical signaling molecules for metabolic adaptation and immune responses, but their dysregulation leads to oxidative stress, mitochondrial DNA damage, and the initiation of apoptotic pathways (1.2.1, 1.4.4). Pharmacological modulation of this system is a key strategy in treating metabolic, oncological, and neurodegenerative disorders (1.1.1, 1.3.2). For example, the biguanide metformin exerts its therapeutic effects in diabetes and potentially cancer through the partial inhibition of Complex I, which reduces hepatic gluconeogenesis and modulates cellular energy sensing (1.1.4, 1.3.4). In oncology, mitocans are developed to selectively disrupt the ETC in malignant cells, leveraging their altered metabolic state to trigger lethal ROS bursts (1.1.1, 1.1.2). Conversely, in conditions characterized by mitochondrial decay, such as Parkinson's disease or aging, therapeutic efforts focus on protecting ETC integrity or utilizing mitochondria-targeted antioxidants like MitoQ to neutralize excessive ROS (1.1.3, 1.2.2). However, the essential nature of mitochondrial function across all tissues presents significant safety challenges, including the risk of systemic lactic acidosis and toxicity to high-energy organs like the heart and brain (1.3.1, 1.3.3).

Other names
Mitochondrial respiratory chainOxidative phosphorylation systemOXPHOSMitochondrial ROSmtROSElectron transport systemRespiratory chain complexes
02

Mechanism of action

Inhibition of respiratory chain complexes (I-IV), modulation of mitochondrial reactive oxygen species (mROS) production, scavenging of mitochondrial free radicals, and stabilization of the mitochondrial inner membrane to maintain bioenergetic efficiency or induce apoptosis.

03

Biological functions

ATP synthesisOxidative phosphorylationRedox signalingApoptosisCell deathMetabolic adaptationThermogenesis
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMetabolic diseaseInflammationMitochondrial disease
05

Safety considerations

Lactic acidosisMitochondrial toxicitySystemic metabolic failureCardiotoxicityNeurotoxicityInduction of unintended apoptosis in healthy tissues
06

Interacting drugs

Metformin

9 more in the full profile.

07

Biomarkers

Growth differentiation factor 15 (GDF-15)Fibroblast growth factor 21 (FGF-21)Blood lactate levelsLactate-to-pyruvate ratio8-hydroxy-2'-deoxyguanosine (8-OHdG)Mitochondrial membrane potential (ΔΨm)

Beyond the preview

Go deeper on Mitochondrial electron transport chain and mitochondrial reactive oxygen species pools (ETC/mROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial electron transport chain and mitochondrial reactive oxygen species pools (ETC/mROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call